GVAG
RLYB icon

Great Valley Advisor Group’s Rallybio RLYB Stock Holding History

Great Valley Advisor Group’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,875
Closed -$10.3K – 1036
2025
Q4 		$10.3K Hold
1,875
– – ﹤0.01% 941
2025
Q3 		$7.49K Hold
1,875
– – ﹤0.01% 922
2025
Q2 		$5.07K Hold
1,875
– – ﹤0.01% 891
2025
Q1 		$9.82K Hold
1,875
– – ﹤0.01% 868
2024
Q4 		$14.4K Buy
+1,875
New +$15.7K ﹤0.01% 840

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Great Valley Advisor Group's RLYB Position: Q1 2026 in Review

Great Valley Advisor Group sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 1,875 shares — an estimated $10.3K sold.

Great Valley Advisor Group first reported a position in RLYB in Q4 2024 and held it in 5 quarters. The position peaked at $14.4K in Q4 2024. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Great Valley Advisor Group reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • Great Valley Advisor Group sold 1,875 Rallybio shares in Q1 2026, an estimated $10.3K.
  • Great Valley Advisor Group first reported a position in Rallybio in Q4 2024 and held it in 5 quarters.
  • Great Valley Advisor Group's Rallybio position peaked at $14.4K in Q4 2024.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.